Skip to content

Measurement of specific IgE antibody levels to identify the causative agent of anaphylaxis

Measurement of specific IgE antibody levels to identify the causative agent of anaphylaxis - Measurement of specific IgE antibody levels to identify the causative agent of anaphylaxis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000026400
Enrollment
10
Registered
2017-03-06
Start date
2017-03-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perioperative anaphylaxis

Interventions

None listed

Sponsors

Gunma University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)The patient with a history of perioperative anaphylaxis 2)The patient whose causative agent of anaphylaxis has been determined by "The study for determining the drug responsible for perioperative anaphylaxis by using skin test and flow cytometry" 3)The patient provided a written consent to participate in this study

Exclusion criteria

Exclusion criteria: 1)The patient doctor judged inappropriate to participate in this study

Design outcomes

Primary

MeasureTime frame
The diagnostic accuracy of specific IgE antibody measurement in the patient with anaphylaxis

Countries

Japan

Contacts

Public ContactShigeru Saito

Gunma University Hospital Department of Anesthesiology

shigerus@gunma-u.ac.jp027-220-8454

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026